Roche Diagnostics currently offers the NT-proBNP test to detect the level of the NT-proBNP peptide as an aid in the diagnosis of congestive heart failure in patients. It also can assess risk stratification in CHF and in acute coronary syndrome. The Elecsys® proBNP immunoassay is approved for use on the Roche Elecsys 1010, Elecsys 2010, and MODULAR ANALYTICS E170 immunoassay analyzers. The American College of Cardiology/American Heart Association practice guidelines recently were updated to include the NT-proBNP test for diagnosis of heart failure and management of heart-failure patients. The guidelines specify that the use of proBNP be recommended in the evaluation of patients presenting within the emergency care setting when heart failure is suspected.
Roche Diagnostics
(317) 845-2000; www.roche-diagnostics.com
